CellGate
Redwood City · Founded 1998
About CellGate
Progen Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of anti-proliferation and cancer therapeutics. The company's products are also used for the treatment of various diseases, including age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia. Progen Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Redwood City, California. Progen Pharmaceuticals, Inc. was formerly known as CellGate, Inc. As a result of the acquisition of Cellgate, Inc. by Progen Pharmaceuticals Limited, Cellgate's name was changed. As of February 7, 2008, Progen Pharmaceuticals, Inc. operates as a subsidiary of Progen Pharmaceuticals Limited (ASX: PGL).
Company Facts
- Founded: 1998
- Legal name: Cellgate Inc.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $72.9M
- Funding stage: M&A
- Last round: Series E (Jun 2003)
- Website: cellgate.com
- Phone: 650-610-7800
Canonical: https://fsome.com/organization/cellgate-8403575 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.